Digital Biomarkers Market Size worth close to USD 36 million by 2035 | Roots Analysis

Digital biomarkers are measurable indicators that are collated using digital health tools, including wearable devices, smartphones and software; these indicators provide objective information regarding a person’s health (by analysing heart rate, blood pressure, sleep cycle and activity pattern).

It is worth highlighting that digital biomarkers play a significant role in advancing precision medicine, enabling timely and targeted interventions based on the person’s health information.

Key Report Takeaways 

§  The digital biomarkers domain is primarily led by emerging firms and start-ups; over 50% of the digital biomarker developers are based in North America (specifically the US)

§  In achieve a competitive edge over other stakeholders, players are actively undertaking initiatives to incorporate advanced features in their respective digital biomarkers

§  Around 40% of the partnerships in this domain were inked in the last two years; further, product / technology integration agreements emerged as the most prominent partnership model adopted by stakeholders

§  Foreseeing a lucrative potential within this domain, several companies have invested significant amount across more than 160 funding instances, since 2015; majority of the funds were raised for developing imaging biomarkers

§  Around 75% of the patents related to digital biomarkers were patent applications while around 30% were granted patents

§  Considering the growing demand for real-time tracking health tools and shift towards personalized therapeutics, digital biomarkers market is anticipated to grow at a significant rate, till 2035

Competitive Landscape:

The digital biomarkers market features more than 220 digital biomarkers. Over 40% of the data collection / analysis tools are software platforms while 40% are mobile applications.

Further, more than 40% of the digital solutions collect / analyze data related to various physiological biomarkers. In terms of digital biomarker developers, the overall landscape seems to be well-fragmented, comprising of large, mid-sized, small and very small players. Nearly 90% of the North America based digital biomarker developers are based in the US while 20% of the firms based in Europe are located in the UK.

Regional Outlook

Based on the key geographical regions, the digital biomarkers market can be segmented into five major regions, including North America, Europe, Asia Pacific, Middle East and North Africa, and Rest of the World. North America is anticipated to capture the majority share of the market in 2024 and this trend is likely to remain unchanged during the forecast period. 

Further, Asia Pacific is accounted to be the fastest-growing segment of the market. The growth of the digital biomarker market in the region is driven by the rising number of decentralized trials and increasing prevalence of chronic diseases in this region. 

Key Players

Examples of key companies engaged in digital biomarkers market (which have also been profiled in this market report; the complete list of companies is available in the full report) include Acculi Labs, ActiGraph, AliveCor, ATCOR, BACtrack, Biogen, BioSerenity, BioSensics, Eyenuk, Empatica, Feel Therapeutics, icometrix, iMediSync, IXICO, Kinsa, Koneksa Health, Kontigo Care, Progentec Diagnostics, Quibim, Vocalis Health.

It is interesting to note that in October 2023, Oura signed a product / technology integration agreement with FitOn to collaboratively offer an exclusive experience of tracking activity, readiness and sleep.

Market Segments

Based on the research, Roots Analysis has segmented the digital biomarkers market into type of product, purpose of solution, type of biomarker, therapeutic area and key geographical regions.

by Type of Product

§  Software / Applications

§  Wearables

§  Sensors

§  Gaming Solutions

by Purpose of Solution

§  Diagnosis Digital Biomarkers

§  Early Screening Digital Biomarkers

§  Monitoring Digital Biomarkers

§  Predictive Insights Digital Biomarkers

by Type of Biomarker

§  Cognitive

§  Idiosyncratic

§  Physiological

§  Vocal

§  Others

by Therapeutic Area

§  Autoimmune Disorders

§  Cardiovascular Disorders

§  Infectious Diseases

§  Mental Health Disorders

§  Neurological Disorders

§  Respiratory Disorders

§  Substance Abuse Disorders

§  Other Disorders

by Type of Business Model

§  B2B

§  B2C

by Key Geographical Regions 

§  North America

§  Europe

§  Asia Pacific

§  Middle East and North Africa

§  Rest of the World

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

Contact US

Gaurav Chaudhary

+1 (415) 800 3415

+44 (122) 391 1091

Email: sales@rootsanalysis.com